SCHEMBL7560414

SCHEMBL7560414

COCCOC(OC1CN(C(=O)O)CCC1c1ccc(OCc2nc(-c3cccs3)no2)cc1)c1ccc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
TSHR P16473 3/20 0.42
FFAR1 O14842 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
REN P00797 2/20 0.39
LMNA P02545 4/20 0.39
MAPK1 P28482 2/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 3/20 0.38
PKM P14618 1/20 0.36
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6043263 0.88 MAPT (0.40) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL7577186 0.85 REN (0.52) MAPTNPC1RAB9ASMN1; SMN2TSHR
Bromide SCHEMBL7563739 0.84 REN (0.52) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL6042729 0.82 REN (0.55) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL6041547 0.82 MAPT (0.43) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL6042439 0.81 MAPT (0.42) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL7562786 0.79 FFAR1 (0.42) FFAR1REN
SCHEMBL6042838 0.78 MAPT (0.44) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL7563407 0.77 REN (0.34) REN
SCHEMBL7563412 0.77 REN (0.34) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076440-A2 METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES ELAN PHARMACEUTICALS, INC. (US) 2002-10-03 WO disclosed